SHEALYN BERRY: Open Payments
NPI 1407416548 · GROVE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 14 payments from 9 companies in 2025. Trend: 2023 $517 · 2024 $37 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $81 |
| PFIZER INC. | 2 | $30 |
| Lilly USA, LLC | 2 | $28 |
| Dexcom, Inc. | 1 | $24 |
| Organon LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: OTEZLA, NURTEC ODT, MOUNJARO, Dexcom G6 Transmitter, NEXPLANON, JARDIANCE, EVENITY, UZEDY.
Industry payments across OK — which companies pay providers there.
